PURCHASE ORDER

PAPZIMEOS IMMUNOTHERAPY

Awarded to ASD SPECIALTY HEALTHCARE, LLC

PIID 36C26027P0048US · USAspendingBiotechnology & Pharmaceuticals
$351.4K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$351,357sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateOct 20, 2026
Company legal name
ASD SPECIALTY HEALTHCARE, LLC
UEI / CAGE
HJ39FBLVE7L5 / Not reported
Parent award
Not reported
Awarding agency
Department of Veterans Affairs
Subagency
Department of Veterans Affairs
Industry
Biotechnology & Pharmaceuticals
NAICS
325412
PSC
6505
Performance period
Not reported — Not reported
Recipient address
5025 PLANO PKWY, CARROLLTON, DENTON, TX, 75010
Place of performance
CARROLLTON, DENTON, TX, 75010
Source last modified
Oct 23, 2026

Description

PAPZIMEOS IMMUNOTHERAPY

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    PAPZIMEOS IMMUNOTHERAPY

    US · usaspendingSource ↗
  2. Value increased

    PAPZIMEOS IMMUNOTHERAPY

    US · usaspending$351.4KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Oct 20, 20260Not reported$351,356.80Not reportedNot reportedPAPZIMEOS IMMUNOTHERAPYUSAspending ↗